EPAZ News! Epazz Patent Pending Blockchain Electric Health

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
148
EPAZ News! Epazz Patent Pending Blockchain Electric Health Care Records Technology Will Help Prevent Data Breaches and Will Support Hyperledger Standards

October 17, 2018 08:30 ET | Source: Epazz, Inc.
Recent US Health and Human Services report on health care data breaches Demonstrates the Need for Our Technology

CHICAGO, Oct. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Epazz, Inc. (OTC: EPAZ), a leading provider of blockchain mobile apps and cloud-based business software solutions, announced today that the company’s patent pending Blockchain Electronic Health Care Records Technology will support Hyperledger standards. Hyperledger is a wide-use open source blockchain solution. Epazz has been using Hyperledger solutions to speed the development of its new blockchain products. The company has been providing electronic health care records cloud software for over six years.

Our patent pending technology will help curb the number of health care data breaches that occur. According to a report from the U.S. Department of Health and Human Services (HHS), there were over 477 health care data breaches in 2017, which affected over 5.579 million patient records. The breaches cost $408 per record. Epazz believes that by using blockchain technology, records will be distributed across the blockchain and will have a level of encryption that can only be unlocked with the patient’s digital key. The company will be developing application programming interfaces, which it will license to other EHRs (Electronic Health Records providers), hospitals and payers.

An article from the Milwaukee Business Journal, “How Blockchain technology is transforming healthcare cybersecurity,” provides more details on how blockchain technology offers many benefits for cybersecurity.

Epazz CEO, Shaun Passley, Ph.D., said, “We are expanding the possibilities of our cloud health care software with the new usages of blockchain to provide our current customers and potential customers greater flexibility and functionality. We believe these efforts will help us increase revenue.”

Epazz reported its unaudited second quarter results for 2018. The company reported revenue of $386,961, compared with $385,163 for the second quarter of 2017. The company reported an operating income of $35,963. This is a substantial turnaround in the company’s financial position. Additionally, the company’s interest expenses have substantially decreased, dropping from $50,973 for the second quarter of 2017 to just $20,062 for the second quarter of 2018.

About Epazz, Inc. (www.epazz.com)

Epazz, Inc., specializes in enterprise cryptocurrency blockchain mobile apps and cloud business process software, with more than 500 repeat customers. The new Bitcoin Mobile app is a financial technology company that offers unique software that allows consumers to acquire Bitcoin at the point of sale. The consumer can then use the cryptocurrency or digital currency to make a purchase at the store with ease. Epazz technology makes it easy to convert legacy systems into cloud business process software, for which the company then charges an annual subscription fee. Epazz has acquired 11 software companies that have converted or are in the process of converting their legacy software products to cloud software using Epazz technology. Epazz then markets the new cloud-based solutions to new and existing customers. Epazz’s other products are DeskFlex™ (a room scheduling software) and Provitrac™ (an applicant-tracking system).

SAFE HARBOR

“Safe Harbor” statement under the Private Securities Litigation Reform Act of 1995: Certain statements contained in this press release are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by their use of forward-looking terminology such as “may,” “expect,” “intend,” “estimate,” “anticipate,” “believe” and “continue” (or the negative forms thereof) or similar terminology. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results or those implied by such forward-looking statements. Investors are cautioned that any forward-looking statements are not guarantees of future performance and that actual results may differ materially from those contemplated by such forward-looking statements. Epazz, Inc. assumes no obligation and has no intention of updating these forward-looking statements, and it has no obligation to update or correct information prepared by third parties that is not paid for by Epazz, Inc. Investors are encouraged to review Epazz, Inc.’s public filings on SEC.gov and otcmarkets.com, including its unaudited and audited financial statements and its OTC markets filings, which contain general business information about the company’s operations, results of operations and risks associated with the company and its operations.

CONTACT: For more information, please contact:

Investor Relations

mailto:investors@epazz.net

(312) 955-8161

www.epazz.com

Epazz, Inc. (EPAZ) Stock Research Links

EPAZ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 89

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 27

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Pathalys' Phase 3 Data Shows Promise for CKD Drug

Updated Category News Views 63

A Glimpse at Pathalys Pharma's Recent Win This is some groundbreaking stuff emerging from Pathalys Pharma. Their investigational drug, upacicalcet, has just clinched a significant victory in two crucial Phase 3 trials - PATH-1 and PATH-2 - aimed at treating Secondary Hyperparathyroidism (SHPT) in patients with end-stage kidney disease undergoing hemodialysis. With SHPT...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 85

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 98

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 66

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
Gildan Faces Lawsuit: Allegations of Deceptive Practices Shake Investors

Updated Category News Views 192

Gildan's Troubles Unveiled The financial jungle can be a pretty treacherous place, and Gildan Activewear Inc. (NYSE: GIL) just found out how fickle the market can be. An 18.7% nosedive in Gildan's stock price after a securities fraud class action came knocking—if that isn't enough to stir up a hornet’s nest among investors, I don’t know what is. The Catalyst:...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 46

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
John Wong's Decade as Estate Planning Specialist

Updated Category News Views 68

One man's legacy isn’t built overnight, especially not in estate planning. And John L. Wong's decade of being a certified specialist by the State Bar of California tells a story of perseverance and grit. Now, at the helm of Modern Wealth Law in Irvine, California, Wong is a name that echoes through the halls of estate planning law with authority and respect. Creating...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading

Top 5 Most Recently Viewed Articles

i3 Verticals' Strategic Shift Boosts Confidence in Future Growth

Updated Category News Views 53

i3 Verticals' Strategic Transformation Enhances Market Position i3 Verticals (NASDAQ: IIIV), recognized for providing integrated payment and software solutions, has recently received a boost in market confidence following the announcement of its significant $438 million divestiture. This strategic decision marks a pivotal moment for the company, allowing it to sharpen its...

Continue Reading
Understanding the Transformative Role of Placental Tissue for Healing

Updated Category News Views 93

Exploring the Benefits of Placental Allografts Marietta, GA – MiMedx Group, Inc. (NASDAQ: MDXG) has recently spotlighted the insights shared in a feature article about placental allografts, which focus on their application for healing complex wounds. This discussion surfaced through a compelling article in a major publication, highlighting the incredible advantages...

Continue Reading
Celebrate Impact: 13 Independent Coffee Shops Thriving Together

Updated Category News Views 326

Crimson Cup Supports Anniversaries of 13 Independent Coffee Shops Crimson Cup Coffee & Tea is proud to acknowledge the special anniversaries of 13 independent coffee houses this month. These remarkable shops are located in various states and have embraced their milestones, ranging from one year to an impressive 13 years of serving delicious coffee. The success these...

Continue Reading
Exploring Key UK Economic Trends Forecasted for 2025

Updated Category News Views 254

Insights on UK Economic Trends for 2025 The new year has arrived, and Deutsche Bank (ETR: DBKGn) has highlighted eight vital themes expected to influence the UK economy as we move further into 2025. Despite current uncertainties, analysts from Deutsche Bank express a level of optimism, indicating that government spending is likely to become a significant contributor to...

Continue Reading
Centene Corporation Reports Impressive Financial Results for 2024

Updated Category News Views 1146

Centene Corporation's Stellar 2024 Financial Overview Centene Corporation (NYSE: CNC) showcased robust financial performance for the year 2024, highlighted by a significant increase in diluted earnings per share (EPS) and revenue growth across various segments. The company's diluted EPS rose to $6.31, with an adjusted diluted EPS reaching $7.17, reflecting a 7% increase...

Continue Reading